Cargando…

MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma

Nonalcoholic fatty liver disease (NAFLD) is a metabolic-related disorder ranging from steatosis to steatohepatitis, which may progress to cirrhosis and hepatocellular carcinoma (HCC). The influence of NAFLD on HCC development has drawn attention in recent years. HCC is one of the most common maligna...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gori, Manuele, Arciello, Mario, Balsano, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972908/ https://www.ncbi.nlm.nih.gov/pubmed/24745023 http://dx.doi.org/10.1155/2014/741465

Ejemplares similares

Mitochondrial Dysfunctions and Altered Metals Homeostasis: New Weapons to Counteract HCV-Related Oxidative Stress
por: Arciello, Mario, et al.
Publicado: (2013)

Environmental Pollution: A Tangible Risk for NAFLD Pathogenesis
por: Arciello, Mario, et al.
Publicado: (2013)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Fang, Zhiqiang, et al.
Publicado: (2021)

Effects of MicroRNAs on Fucosyltransferase 8 (FUT8) Expression in Hepatocarcinoma Cells
por: Bernardi, Cinzia, et al.
Publicado: (2013)

Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease
por: Soronen, Jarkko, et al.
Publicado: (2016)

The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease
por: Kim, Yumi, et al.
Publicado: (2021)

MicroRNAs and Nonalcoholic Steatohepatitis: A Review
por: Morishita, Asahiro, et al.
Publicado: (2023)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload
por: Arciello, Mario, et al.
Publicado: (2015)

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
por: Qi, Xiaoyan, et al.
Publicado: (2022)

Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis
por: Zhu, Yuezhi, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells
por: Riedel, Rodrigo, et al.
Publicado: (2019)

MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
por: Sun, Hao, et al.
Publicado: (2023)

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
por: Tan, Youwen, et al.
Publicado: (2014)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
por: Pirozzi, Anna Virginia Adriana, et al.
Publicado: (2020)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device
por: Gori, Manuele, et al.
Publicado: (2016)

Global Assessment of Antrodia cinnamomea-Induced MicroRNA Alterations in Hepatocarcinoma Cells
por: Chen, Yen-Ju, et al.
Publicado: (2013)

Focal Adhesion Kinase (FAK) Mediates the Induction of Pro-Oncogenic and Fibrogenic Phenotypes in Hepatitis C Virus (HCV)-Infected Cells
por: Alisi, Anna, et al.
Publicado: (2012)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat
por: Quintás, Guillermo, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
por: Rimini, M., et al.
Publicado: (2021)

Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
por: Pillai, Sneha S., et al.
Publicado: (2020)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
por: Pirmoazen, Amir M., et al.
Publicado: (2020)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
por: Shao, Congxiang, et al.
Publicado: (2022)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease
por: Yu, Jingwei, et al.
Publicado: (2019)

MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice
por: Yu, Yuanjie, et al.
Publicado: (2022)

Data on differentially expressed microRNAs in the liver between nonalcoholic fatty liver disease and normal Wistar rat using Solexa sequencing
por: Zhang, Deqing, et al.
Publicado: (2016)

Effects of the Olive-Derived Polyphenol Oleuropein on Human Health
por: Barbaro, Barbara, et al.
Publicado: (2014)

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
por: Rom, Oren, et al.
Publicado: (2019)

Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells
por: Khalifa, Olfa, et al.
Publicado: (2023)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k477eno4sql8ise3dm5cai4dlh